Mullen James C
SEC-identified person · CIK 1226288 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Thermo Fisher Scientific INC. TMO | Director | filed 2018 - 2025 |
| Editas Medicine, Inc. EDIT | Director · CEO | filed 2018 - 2022 |
| Insulet Corp PODD | Director | filed 2017 - 2018 |
| Patheon N.V. PTHN | Director · Chief Executive Officer | filed 2016 - 2017 |
| Revvity, INC. RVTY | Director | filed 2006 - 2014 |
| Patheon INC PTI | Director · Chief Executive Officer | filed 2011 - 2014 |
| Biogen INC. BIIB | Director · CEO & President | filed 2006 - 2010 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.